Ressources

Bienvenue dans notre banque interrogeable de ressources et de documentation sur l’approvisionnement plus sécuritaire et autres sujets connexes.

 

 
Commentary | 2023
Safer supply, Policy/Regulatory

We examined the association between sex work and overdose and secondarily explored the association of social-structural factors, such as policing and gendered violence, with overdose.

Original research | 2023
Overdose, Sex/Gender
Handout | 2022
Illegal drugs, Harm reduction

This study aimed to identify lower-risk substance use guidelines (LRSUGs) accessible to youth and to characterize the recommendations within these guidelines.

Original research | 2023
Harm reduction, Youth

Cette étude explore les points de vue des coroners et des médecins légistes concernant les facteurs de risque contextuels et les caractéristiques associés aux décès causés par les effets toxiques a

Recherche | 2023
la surdose, la mortalité

This study explored coroner and medical examiner (C/ME) perspectives of contextual risk factors and characteristics associated with deaths from acute toxic effects of opioids and other

Original research | 2023
Overdose, Mortality

Cette étude établit les caractéristiques de la mortalité liée aux opioïdes dans la région de KFLA dans le but d’améliorer la compréhension du phénomène des surdoses d’opioïdes au sein

Recherche | 2023
les villes petites et moyennes, la surdose, la mortalité

This study characterized opioid-related mortality in KFL&A, to enhance understanding of opioid overdoses in these smaller communities.

Original research | 2023
Small/medium cities, Overdose, Mortality

This study examines factors associated with receptive injection equipment sharing among people who inject drugs in the context of COVID-19.

Original research | 2023
About PWUD, Injecting drugs, Harm reduction

Although stigma reduction is a key goal of federal strategies to prevent overdose, there is limited data to assess progress made in reducing use of stigmatizing language about addiction.

Original research | 2023
Stigma

This study examined whether an online training incorporating patient narratives reduced primary care clinicians' (PCCs) stigma toward people with opioid use disorder (primary) and increased intenti

Original research | 2023
About prescribers, Stigma

While daily witnessed opioid agonist treatment (OAT) ingestion is common in British Columbia (BC), Canada, and elsewhere, sparse evidence supports this resource-intensive practice.

Original research | 2023
Policy/Regulatory, Advocacy
Original research | 2023
Policy/Regulatory, Mental health

We developed a survey to assess clinician self-reported barriers, perceptions, and practices for treating HCV-infected patients with SUD and the associations of these barriers, perceptions, and pra

Original research | 2023
About prescribers, Barriers and enablers
Webpage | 2023
Clinical guidance, Harm reduction, About prescribers

We conducted a process evaluation of a novel harm reduction-oriented addiction medicine consultation team [AMCT].

Original research | 2019
Harm reduction, Hospitals
Commentary | 2008
Harm reduction, Equity, Policy/Regulatory

Affiner votre recherche

Mots clés
Format
Région